About

Mr. Donohue has served as a director of Acurx since July 2021. Since April 2004 he has been a Vice President with Charles River Associates (Nasdaq: CRAI), a global economic, financial and management consulting firm, and he has more than 30 years of experience in valuation, damages and forensic accounting. He is a Certified Public Accountant in Maryland, a Certified Valuation Analyst and Accredited in Business Valuation, and holds a B.S. in Accountancy from Villanova University.

Roles

Acurx Pharmaceuticals, Inc.
Director · Current role
July 2021–present
Charles River Associates (CRAI)
Vice President
2004 - present

Director Compensation

FY 2024
Fees earned or paid in cash
$55,000
ComponentAnnual cash retainers and committee/leadership fees earned in 2024
Option awards
$22,104
ComponentStock options granted during 2024, ASC 718 grant-date fair value
Total
$77,104

Also at Acurx Pharmaceuticals, Inc.

Related

See how VectorShift works for your firm

Request Demo